Human Mass Balance Study of HMS5552 in Healthy Subjects

Summary

This is an open-label, single center, 1-period study in healthy adult male subjects to assess absorption, metabolism, and excretion of HMS5552 after a single oral administration of 50 mg (90 μCi) of \[14C\]-HMS5552.

Timeline

Start

2017-03-29

Primary completion

2017-04-06

Completion

2017-04-06

Drugs

Indications

No indication recorded.